GSK’s Penmenvy meningococcal vaccine gains FDA approval
The CDC's ACIP is set to vote on the use of GSK's MenABCWY vaccine on 26 February 2025.
Medical Devices
Prothea debuts with $13m to develop cancer diagnostics and treatment
Alebund receives ODD for investigational drug AP303
NVIDIA doubles down on AI in healthcare with drug discovery deals
Setting up trials in APAC and Middle East can boost patient recruitment
FluoGuide imaging agent wins FDA orphan drug designation for glioma surgery
FDA approves Empaveli injector for PNH patients
Sun rises on Lithuania’s life sciences industry
